- Home
- CABO vs RCKT Comparison
CABO vs RCKT Comparison
Compare CABO & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABO
- RCKT
- Stock Information
- Founded
- CABO 1980
- RCKT 1999
- Country
- CABO United States
- RCKT United States
- Employees
- CABO N/A
- RCKT N/A
- Industry
- CABO Cable & Other Pay Television Services
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- CABO Telecommunications
- RCKT Health Care
- Exchange
- CABO Nasdaq
- RCKT Nasdaq
- Market Cap
- CABO 2.0B
- RCKT 1.9B
- IPO Year
- CABO N/A
- RCKT N/A
- Fundamental
- Price
- CABO $342.36
- RCKT $17.13
- Analyst Decision
- CABO Hold
- RCKT Strong Buy
- Analyst Count
- CABO 5
- RCKT 9
- Target Price
- CABO $556.40
- RCKT $53.22
- AVG Volume (30 Days)
- CABO 75.9K
- RCKT 731.3K
- Earning Date
- CABO 11-07-2024
- RCKT 11-04-2024
- Dividend Yield
- CABO 3.55%
- RCKT N/A
- EPS Growth
- CABO 225.28
- RCKT N/A
- EPS
- CABO 35.76
- RCKT N/A
- Revenue
- CABO $1,630,937,000.00
- RCKT N/A
- Revenue This Year
- CABO N/A
- RCKT N/A
- Revenue Next Year
- CABO N/A
- RCKT $300.20
- P/E Ratio
- CABO $9.30
- RCKT N/A
- Revenue Growth
- CABO N/A
- RCKT N/A
- 52 Week Low
- CABO $311.28
- RCKT $15.98
- 52 Week High
- CABO $618.44
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- CABO 45.61
- RCKT 46.41
- Support Level
- CABO $330.90
- RCKT $17.05
- Resistance Level
- CABO $350.65
- RCKT $17.75
- Average True Range (ATR)
- CABO 10.83
- RCKT 0.72
- MACD
- CABO -0.56
- RCKT 0.06
- Stochastic Oscillator
- CABO 19.18
- RCKT 40.23
About CABO Cable One Inc.
Cable One Inc is a telecommunications company. It derives revenue from the provision of broadband, voice, and video services to residential and business customers. From a product perspective, the majority of revenue is sourced from data and video services. This revenue is subscription-based and billed monthly. The company also offers Sparklight TV, an internet protocol-based (IPTV) video service that allows customers with Sparklight TV app to stream video channels from the cloud. The company also derives advertising revenue from selling airtime on its video channels. Voice services are offered over Internet protocols. The company owns a telecommunications infrastructure.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.